T Yano, Z Liu, J Donovan, MK Thomas, JF … - Diabetes, 2007 - Am Diabetes Assoc RESULTS—CXCR4 is expressed in β-cells, and SDF-1 is expressed in
microvascular endothelial cells within the islets and in surrounding
interstitial stromal tissue. Transgenic mice overexpressing SDF-1 within ... Cited by 9 - Related articles - BL Direct - All 4 versions
E Aboumrad, AM Madec, C Thivolet - Clinical and Experimental Immunology, 2007 - pubmedcentral.nih.gov Chemokines and their receptors are part of polarized T helper 1 (Th1)- and
Th2-mediated immune responses which control trafficking of immunogenic cells to
sites of inflammation. The chemokine stromal cell-derived factor-1 CXCL-12 ... Cited by 6 - Related articles - BL Direct - All 5 versions
Q Leng, Y Nie, Y Zou, J Chen - BMC immunology, 2008 - biomedcentral.com Type I diabetes (TID) is an autoimmune disease resulting from destruction of the
insulin-producing β-cells by autoreactive T cells. Studies have shown that
polymorphisms of chemokine CXCL12 gene are linked to TID in humans. In ... Cited by 2 - Related articles - Cached - All 6 versions
[CITATION] Differential hypothalamic neuronal activation after peripheral injection of GLP-1 and …
OB Chaudhri, JR Parkinson, YT Kuo, MR Druce … - Biochem Biophys Res Commun, 2006 Cited by 2 - Related articles
- ►physiology.org ET Parlevliet, AC Heijboer, JP Schroder-van … - American Journal of Physiology- Endocrinology And …, 2008 - Am Physiological Soc We evaluated the acute effects of OXM on glucose metabolism in diet-induced
insulin-resistant male C57Bl/6 mice. To determine the effects on glucose
tolerance, mice were intraperitoneally injected with OXM (0.75, 2.5, or 7.5 ... Cited by 4 - Related articles - BL Direct - All 3 versions
K Toyoda, T Okitsu, S Yamane, T Uonaga, X … - Biochemical and Biophysical Research …, 2008 - Elsevier To clarify the cytoprotective effect of glucagon-like peptide-1 receptor
(GLP-1R) signaling in conditions of glucose toxicity in vivo, we performed
murine isogenic islet transplantation with and without exendin-4 treatment. ... Cited by 5 - Related articles - All 3 versions
- ►aspetjournals.org R Jorgensen, V Kubale, M Vrecl, TW Schwartz … - Journal of Pharmacology and Experimental …, 2007 - ASPET The glucagon-like peptide (GLP)-1 receptor is a promising target for the
treatment of type 2 diabetes and obesity, and there is great interest in
characterizing the pharmacology of the GLP-1 receptor and its ligands. In ... Cited by 8 - Related articles - All 4 versions
[CITATION] The long-acting albumin-exendin-4 GLP-1R agonist CJC-1134 engages central and …
LL Baggio, Q Huang, DJ Drucker - Program and abstracts of the American Diabetes …, 2006 Cited by 8 - Related articles
SG Sayyed, H Hägele, OP Kulkarni, K Endlich … - Diabetologia, 2009 - Springer Abstract Aims/hypothesis Chemokine (CXC motif) ligand 12 (CXCL12) (also known as
stromal cell-derived factor-1 [SDF-1]-alpha) is a homeostatic chemokine with
multiple roles in cell homing, tumour metastasis, angiogenesis and tissue ... Related articles - All 2 versions
J Takaya, Y Fujii, H Higashino, S Taniuchi, … - Pediatric Diabetes, 2008 - interscience.wiley.com Abstract: The WHIM syndrome is a rare immunological disorder characterized by
warts, hypogammaglobulinemia, infections, and myelokathexis. We hypothesized
that immunological or genetic mechanisms may link WHIM syndrome and type 1 ... Related articles - All 2 versions
